The aim of the present study was to evaluate the diagnostic value of CERT1 in a group of subjects with obesity without (OB-MetS−) or with (OB-MetS+) metabolic syndrome, compared to an age- and sex-matched group of normal-weight (NW) subjects. The gene discussed is CERT1; the disease is metabolic syndrome.